福巴替尼的购买渠道

Futibatinib is a targeted drug for the treatment of FGFR2 gene fusion cholangiocarcinoma. Its research and development targets focus on patients with FGFR2 gene fusion/rearrangement of cholangiocarcinoma. Its purchasing channels, marketing progress and price information are crucial to patient treatment choices. This article systematically introduces the latest status of these three key aspects and provides patients with reliable medication guidance.

Purchase channels for forbatinib

Due to the particularity of the drug, patients need to obtain it through formal channels to ensure the quality of the drug.

International formal purchase

In approved countries such as the United States and Japan, patients can purchase original drugs at designated pharmacies with a prescription from an oncologist. Medical certificates such as pathology reports and genetic test results are required.

Cross-border drug purchase methods

Patients can purchase Lao version of generic drugs through medical service institutions with cross-border drug business qualifications. They need to prepare original prescriptions, diagnosis certificates, identity certificates and other materials, and complete the customs declaration process.

It is recommended to choose formal channels that provide drug traceability services and professional pharmaceutical guidance to avoid purchasing drugs from unknown sources.

The marketing status of forbatinib

Understanding the approval progress of forbatinib in various regions around the world will help patients plan treatment plans.

International approval process

It received accelerated approval from the US FDA in September 2022, passed certification from the Japanese Ministry of Health, Labor and Welfare in June 2023, and was approved by the EU EMA in July. The product name is Lytgobi.

China marketing progress

Currently, a marketing application has not been submitted to China’s State Food and Drug Administration. It has not been launched in China and cannot be purchased directly in domestic hospital pharmacies or pharmacies.

The development status of generic drugs

Laos has approved the listing of locally produced generic drugs. Generic drugs in India, Bangladesh and other countries are still in the research and development stage and have not received official approval.

As more regions around the world approve the drug, the channels for patients to obtain the drug will gradually expand.

The price of fobatinib

As an innovative targeted drug, the price structure of fobatinib has an important impact on patient treatment decisions.

Price of generic drugs

The generic drug produced by Lucius in Laos is priced at US$480 for 4mg*35 tablets. Based on standard dosage, the monthly treatment cost is about US$820, and the annual cost is about US$9,800.

Cost influencing factors

Drug specifications, purchasing channels, transportation costs, exchange rate fluctuations, etc. will all affect the final price. Medical insurance reimbursement can reduce costs by 50%-70%.

Patients can choose a suitable source of medicines based on their economic status and consult professional cross-border medical service agencies when necessary.